Needle-Free hope: new shot delivery may ease myeloma treatment

NCT ID NCT05704049

Ongoing Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug combination (isatuximab, carfilzomib, and dexamethasone) given under the skin to adults whose multiple myeloma has returned or stopped responding to prior treatments. The main goal is to see how well the cancer responds and to compare two ways of giving the shot: by hand or using a wearable device. About 118 participants will be enrolled, and the study is currently active but no longer recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED/REFRACTORY MULTIPLE MYELOMA

Contacts and locations

Locations

Clinica São Germano- Site Number : 0760003

São Paulo, 04537-080, Brazil
Hospital Mae de Deus Site Number : 0760002

Porto Alegre, Rio Grande do Sul, 90880-480, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760001

São Paulo, 05403-000, Brazil
Investigational Site Number : 0360001

Melbourne, Victoria, 3065, Australia
Investigational Site Number : 0360002

Wollongong, New South Wales, 2500, Australia
Investigational Site Number : 1560001

Tianjin, 300020, China
Investigational Site Number : 1560002

Guangzhou, 510060, China
Investigational Site Number : 1560003

Wuhan, 430030, China
Investigational Site Number : 1560004

Shenyang, 110004, China
Investigational Site Number : 1560005

Nanchang, 330006, China
Investigational Site Number : 1560006

Changsha, 410013, China
Investigational Site Number : 1560007

Tianjin, 300060, China
Investigational Site Number : 2030001

Prague, 128 08, Czechia
Investigational Site Number : 2030002

Brno, 625 00, Czechia
Investigational Site Number : 2030003

Ostrava, 708 52, Czechia
Investigational Site Number : 2030004

Olomouc, 779 00, Czechia
Investigational Site Number : 3000001

Athens, 106 76, Greece
Investigational Site Number : 3000002

Athens, 115 28, Greece
Investigational Site Number : 3920001

Kashiwa, Chiba, 277-8577, Japan
Investigational Site Number : 3920002

Okayama, 701-1192, Japan
Investigational Site Number : 6200001

Braga, 4710-243, Portugal
Investigational Site Number : 6200004

Lisbon, 1400-038, Portugal
Investigational Site Number : 6200005

Lisbon, 1649-035, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.